Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Wool Research Organisation Of New Zealand Incorporated currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. The prosecution activity is confined to a distinct examiner and a distinct art unit. This indicates a singular focus for the company's current patent office interactions. Such a concentrated workload allows for a deep dive into the specific technical requirements of the Biotechnology & Pharmaceuticals field as they apply to this single matter. The administrative overhead is minimized by the lack of multiple pending actions.
CHANG, KYUNG SOOK is the busiest examiner assigned to the portfolio, holding 1 busiest examiner pending office action. This examiner manages the full extent of the company's pending office action workload. Success in this technology area will depend on navigating the specific examination style of this individual within the Biotechnology & Pharmaceuticals framework. The presence of a distinct art unit simplifies the technical focus required for these proceedings. Practitioners should prioritize understanding this examiner's previous decisions to better anticipate the trajectory of the pending office action.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHANG, KYUNG SOOK | 1 | 60.4% | +40.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17264755 | Keratin Compositions | CHANG, KYUNG SOOK | 46d overdue |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17264755 | Keratin Compositions | CHANG, KYUNG SOOK | 1613 | §103 | Non-Final OA | 46d overdue | Pending | Jan 29, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial